IPT no good for TB control ‘ Thibela study
The Thibela TB study provided clear evidence that community-wide TB preventive therapy did not improve TB control at a population level even though it was effective in reducing the risk of TB among individuals taking the prophylaxis isoniazid.
The study targeted over 27 000 miners in a study which was based on finding, treating and preventing TB across an entire workforce of eight gold mines.
TB remains the principle cause of death among the mining workforce and the incidence is between three and six times higher than in the general population.
The programme provided community-wide isoniazid preventive therapy (IPT) in eight gold mines, but was found to not improve TB control.
However, evidence showed that there were 63% fewer TB cases among individuals in the programme during the first nine months of the programme, providing reassurance that IPT works for people who take it. The benefit was reduced and disappeared once they stopped taking the IPT after nine months.
The Thibela TB project, was carried out by the South Africa-based Aurum Institute and London School of Hygiene and Tropical Medicine, and was launched in response to the need to introduce a radical method of TB control in South African gold mines.
The initial results of the Thibela TB study were announced yesterday (SUBS: FRI) at the 19th Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle. Final results are expected to be announced at the South African TB Conference in June.
Professor Gavin Churchyard, principal investigator and CEO of the Aurum Insitute was due to present the findings to Bill Gates in a private forum this morning (SUBS: FRI)(last night in Seattle). The Bill and Melinda Gates Foundation funded the study.
An upbeat Churchyard said despite the disapppointment, ‘Thibela has been a roaring success’.
‘We asked an important question and we have a clear result. We needed to evaluate a strategy to control TB and we will now be able to save money and time,’ said Churchyard.
He said they would be able to use the huge amount of rich data for modeling to explore other strategies that may work.
The study was the largest ever carried out in South Africa and one of the biggest in the world.
Author
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
IPT no good for TB control ‘ Thibela study
by Anso Thom, Health-e News
March 8, 2012